| Journal | JAMA internal medicine |
| Study Type | Clinical Study |
| Population | Human participants |
This comprehensive review addresses a critical clinical gap where patients increasingly self-medicate mental health conditions with cannabis despite limited evidence. The findings provide essential guidance for risk-benefit discussions that occur daily in clinical practice.
This systematic review examined evidence for cannabis in treating mental health conditions including PTSD, anxiety, depression, and ADHD. The authors found low-certainty evidence that THC-predominant cannabis does not improve PTSD symptoms, with largely insufficient evidence for other conditions. Emerging low-certainty evidence suggests CBD alone may reduce anxiety in anxiety disorders. The review emphasizes substantial risks of adverse mental health effects from THC-predominant cannabis use.
“This review confirms what I observe clinically – patients often have unrealistic expectations about cannabis for mental health while underestimating risks. The distinction between CBD and THC effects is crucial for informed clinical decision-making.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Is cannabis effective for treating PTSD symptoms?
Current evidence suggests THC-predominant cannabis may not improve PTSD symptoms, with only low-certainty evidence available. Clinicians should be aware that despite patient reports of symptom relief, robust scientific support for cannabis as a PTSD treatment is lacking.
Can CBD help with anxiety disorders?
There is emerging low-certainty evidence that cannabidiol (CBD) alone may reduce anxiety in patients with anxiety disorders. However, more research is needed to establish definitive clinical recommendations and optimal dosing protocols.
What are the mental health risks of THC-predominant cannabis use?
THC-predominant cannabis use carries substantial risk for adverse mental health effects. Clinicians should counsel patients about these risks, particularly given the insufficient evidence for therapeutic benefits in most mental health conditions.
Is there evidence supporting cannabis use for depression and ADHD?
There is largely insufficient evidence to characterize the effects of long-term THC-predominant cannabis use on depression and ADHD symptoms. The potential benefits for these conditions remain poorly studied despite common patient use.
Should I recommend cannabis to patients with mental health conditions?
Given the lack of clear benefits and potential for substantial adverse effects, cannabis should not be routinely recommended for mental health conditions. Clinicians should prioritize evidence-based treatments while remaining informed about emerging research on specific cannabinoids like CBD.
